Dr. Locke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Community Dr
Manhasset, NY 11030
Summary
- Margaret Locke, MD, is an oncology fellow and board certified internal medicine physician. She earned her MD from Northwestern University Feinberg School of Medicine and completed her residency in Internal Medicine at the Zucker School of Medicine at Hofstra/Northwell. She is well cited in peer reviewed journals in the fields of hematologic malignancies as well as head/neck and thoracic cancers.
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2024 - 2027
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2021 - 2024
- Northwestern University The Feinberg School of MedicineClass of 2021, MD
- Duke UniversityBS, Magna Cum Laude, 2013 - 2017
Certifications & Licensure
- NY State Medical License 2024 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas.Margaret Locke, Nina Kohn, Nagashree Seetharamu
Clinical Otolaryngology. 2023-11-01 - 1 citationsFIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus.Margaret Locke, Rachel M Suen, Alex K Williamson, Maria J Nieto
Cureus. 2023-08-01 - 3 citationsAnalysis of Updates in Multiple Myeloma Treatment and Management.Maria Jacqueline Nieto, Aryles Hedjar, Margaret Locke, Jessica Caro, Muhammad Wasif Saif
Journal of Clinical Haematology. 2023-01-01
Press Mentions
- Lymphovascular Invasion May Be a Key Predictor for Postoperative Recurrence of NSCLCJanuary 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: